Continuous Glucose Monitoring for Non-Diabetics: Biohacking Fad or Metabolic Insight?
For more than two decades, continuous glucose monitors (CGMs) were strictly classified as prescription-only medical hardware engineered specifically for individuals diagnosed with Type 1 and advanced Type 2 diabetes. However, in 2026, the intersection of over-the-counter biosensor availability, wearable health tracking, and preventative metabolic medicine has unleashed a mainstream consumer revolution. Today, millions of non-diabetic […]
Read More